| Financial Year |
March 31 2023 |
| Monetary Funds |
1,736,172,911.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
239,390,130.23 |
| Accounts Receivable |
249,453,938.87 |
| Advances to Suppliers |
79,631,011.04 |
| Other Receivables |
17,152,762.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,000,000.00 |
| Inventories |
745,847,560.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
163,256,347.80 |
| Total Current Assets |
3,310,658,168.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,313,539,293.54 |
| Investment Properties |
-- |
| Fixed Assetes |
2,809,424,178.76 |
| Under-construction Projects |
1,466,098,150.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,390,817,858.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
77,720,670.64 |
| Deferred Income Tax Assets |
36,767,316.50 |
| Other Non-Current Assets |
287,624,870.45 |
| Sub-Total of Non-Current Assets |
7,436,254,676.74 |
| Total Assets |
10,746,912,844.78 |
| Short-Term Loans |
1,116,462,958.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
601,427,934.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,329,117.50 |
| Taxes Payable |
46,151,827.46 |
| Interest Payable |
3,982,793.83 |
| Dividend Payable |
-- |
| Other payables |
206,463,396.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
319,960,680.08 |
| Other Current Liabilities |
145,315,914.98 |
| Sub-Total of Current Liabilities |
2,544,674,808.22 |
| Long-term Loans |
1,852,708,751.89 |
| Bonds Payable |
931,622,473.08 |
| Long-Term Accounts Payable |
44,400,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
41,795,343.45 |
| Deferred Income Tax Liabilities |
128,482,628.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,036,202,560.31 |
| Total Liabilities |
5,580,877,368.53 |
| Paid-In Capital(Or Share Stock) |
501,821,017.00 |
| Capital Surplus |
1,852,844,312.42 |
| Surplus Reserve |
182,056,209.41 |
| LESS:Treasury Stock |
96,127,840.00 |
| Undistributed Profits |
1,911,234,908.38 |
| Minority Stockholder's Interest |
605,411,179.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,560,624,296.72 |
| Owner's Equity（Stockholder's Equity） |
5,166,035,476.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,746,912,844.78 |
